Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies. Nexo combines covalent ligand discovery and chemical biology with expertise in cancer biology and medicinal chemistry to target fundamental drivers of cancer by innovative approaches. With facilities in Golden, CO and Watertown, MA, Nexo is led by Founder and CEO, Andrew Phillips, PhD. For more information, please visit www.nexotx.com.

Biotechnology

Life Sciences

Therapeutics

Nexo Therapeutics

Nexo Therapeutics' headquarters in Watertown, United States

Andrew Phillips

Aidan Finley

Rhamy Zeid

Michael Kim

The Research and Chemistry Team at Nexo Therapeutics spearheads the discovery and development of novel small molecule drugs for oncology. This interdisciplinary team employs computational chemistry, chemical biology, and medicinal chemistry to design and optimize compounds that target key drivers of cancer. Through a collaborative effort, they focus on translating cutting-edge science into viable therapeutic options for cancer patients.

Research and Chemistry Team

The Leadership Team at Nexo Therapeutics is responsible for setting the strategic direction, overseeing critical research and development initiatives, and managing the company's operations to advance the discovery and development of new cancer therapies. Comprising roles such as CEO, VP Heads of Biology and Discovery, Principal Scientist, and Chief Operating Officer, this team integrates expertise in science and business to drive innovation and ensure operational excellence across the company's facilities in Golden, CO, and Watertown, MA.

Nexo Therapeutics

Org chart

Teams

Research and Chemistry Team

Leadership Team

Offices

Nexo Therapeutics

Org chart

Teams

Research and Chemistry Team

Leadership Team

Offices

Related companies